z-logo
Premium
Heterogeneity of tumour‐infiltrating lymphocytes in breast cancer and its prognostic significance
Author(s) -
Althobiti Maryam,
Aleskandarany Mohammed A,
Joseph Chitra,
Toss Michael,
Mongan Nigel,
DiezRodriguez Maria,
Nolan Christopher C,
Ashankyty Ibraheem,
Ellis Ian O,
Green Andrew R,
Rakha Emad A
Publication year - 2018
Publication title -
histopathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.626
H-Index - 124
eISSN - 1365-2559
pISSN - 0309-0167
DOI - 10.1111/his.13695
Subject(s) - breast cancer , medicine , oncology , pathology , cancer
Background and aims Tumour‐infiltrating lymphocytes ( TIL s) in breast cancer ( BC ) provide prognostic and predictive information. The aim of this study was to assess the spatial and temporal heterogeneity of TIL s in BC and its relationship with immune cell subtypes. Methods and results Immunohistochemically defined immune cell subtypes, i.e. those expressing T‐cell markers ( CD 3, CD 8, and FOXP 3), a B‐cell marker ( CD 20) and a histiocytic marker ( CD 68), were evaluated in a large series ( n  = 1165) of invasive BC s. A subset of full‐face haematoxylin and eosin (H&E)‐stained slides were examined for TIL s heterogeneity within primary tumours and the corresponding local recurrent carcinomas to investigate spatial and temporal TIL s heterogeneity. H&E‐stained sections from multiple tumour blocks (three or four blocks per case) representing different tumour areas were evaluated to assess TIL s interslide heterogeneity and intraslide heterogeneity. Both average stromal TIL s ( AV ‐ TIL s) and hotspot stromal TIL s ( HS ‐ TIL s) were assessed. AV ‐ TIL s showed associations with all immune cell subtypes; however, CD3+ cells constituted the main component (mean number of CD3+ was 55), whereas CD 20+ cells constituted the smallest component (mean number of CD20 was 13). There was no significant statistical difference between TIL s across tumour blocks of the same case ( P  = 0.251 for AV ‐ TIL s and P  = 0.162 for HS ‐ TIL s). Triple‐negative breast cancer ( TNBC ) showed higher TIL s percentage than other BC subtypes ( P  < 0.001). High AV ‐ TIL s, CD 3+ cells, CD 8+ cells and CD 20+ cells were associated with longer survival in TNBC patients ( P  < 0.05). High AV ‐ TIL s in recurrent tumours showed a significant association with shorter post‐recurrence survival ( P  = 0.004). Conclusions Despite the heterogeneity of immune cell type components, average TIL s in one full‐face H&E‐stained section reliably represent TIL s in the whole tumour. TIL s were associated with outcome in TNBC patients, as well as having prognostic significance for recurrent tumours.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here